M&A Update – Jan 6

– RVNC / Teoxane submit unsolicited proposal at $3.60 cash per share, 16.1% premium to Crown Laboratories’ friendly $3.10 deal
– PFIE / CECO deal closed
– ROIC / BX filed DEFM14a, vote Feb 7, closing Q1 2025
– CCRN / Aya Healthcare filed PREM14a, filed HSR Dec 17, closing H1 2025
– FIL.to / LUN.to obtained all key regulatory approvals, closing Jan 15
– DFS / COF filed S-4/a, closing early 2025
– PSTX HSR expires, filed delisting notice
– SUM HSR expires